Laguna Bio

lagunabio.com

lagunabio.com • Likely startup • New

Likely startup • New

Cell & Gene Therapy

Biotechnology

Claim pageClaim

Overview

Salaries

Products

People

Growth

Offices

Financials

Funding and backers

Backers

SOSV

Momentum

0/100

no fresh signals

Backed byfrom the funds' portfolios and accelerator catalogs

SOSV accelerator

Investors in similar startupsfunds that back the companies most like this one

backs Waypoint Bio

backs AvenCell

backs Endura

backs AvenCell

backs Alia therapeutics

Hummingbird Ventures

backs Waypoint Bio

Similar startupsby what they do, their industry and backers

ALKemist BioVenture round $7.5M · 2 yr ago • 11-50 employees

ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune…

Endura11-50 employees

The RNA covalency company. Endura's small molecule drugs form an enduring bond with an mRNA, blocking translation and knocking down…

Waypoint Bio11-50 employees

Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.

Alia therapeuticsSeed $4.8M · 3 yr ago • 11-50 employees

Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.

CellVax TherapeuticsVenture round $2.1M · 2 yr ago • Founded 2020 • 1-10 employees

At CellVax Therapeutics, we are developing the Next Generation of Personalized Immunotherapy.

MediSix Therapeutics

MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.

Overview

Laguna is a biotechnology company developing next-generation attenuated microbial platforms that have the predictable PK/PD of small molecule drugs and activate the precise combination of signals required for T cells to find and kill cancer.